ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
Dow Jones
42.732,13
0,80%
Euro vs US Dollar
1,03115
0,00%
Bitcoin
98.365,96
0,16%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Kiromic BioPharma Inc (KRBP)

  7. Kiromic BioPharma Inc (KRBP) News

KRBP

Kiromic BioPharma (KRBP)

Kiromic BioPharma Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:KRBP
DatumZeitQuelleÜberschriftSymbolFirma
19/09/202422h30Business WireKiromic BioPharma Activates the University of Arizona Cancer Center as the Fifth Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 TrialNASDAQ:KRBPKiromic BioPharma Inc
19/09/202414h00Business WireKiromic BioPharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee’s Unanimous RecommendationNASDAQ:KRBPKiromic BioPharma Inc
21/08/202422h29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
14/08/202414h00Business WireKiromic BioPharma’s Deltacel Receives FDA Fast Track DesignationNASDAQ:KRBPKiromic BioPharma Inc
09/08/202421h04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KRBPKiromic BioPharma Inc
09/08/202414h00Business WireKiromic BioPharma Provides Update on Part 1 of the Deltacel-01 TrialNASDAQ:KRBPKiromic BioPharma Inc
01/08/202414h00Business WireKiromic BioPharma Reports 20% Tumor Size Reduction at Eight Months in First Patient Enrolled in Deltacel-01NASDAQ:KRBPKiromic BioPharma Inc
18/07/202414h00Business WireKiromic BioPharma to Advance Deltacel-01 Clinical Trial to Part 2, Expansion PhaseNASDAQ:KRBPKiromic BioPharma Inc
28/06/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
27/06/202423h21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
20/06/202414h00Business WireKiromic BioPharma Provides Updates on its Deltacel-01 Clinical TrialNASDAQ:KRBPKiromic BioPharma Inc
14/06/202400h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
13/06/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
12/06/202422h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
12/06/202422h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
07/06/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
06/06/202414h00Business WireKiromic BioPharma Reports Six-Month Results from First Patient Enrolled in Deltacel-01 Clinical TrialNASDAQ:KRBPKiromic BioPharma Inc
04/06/202423h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
29/05/202414h00Business WireKiromic BioPharma Reports Favorable Results at Six Weeks from Fourth Patient in Deltacel-01 Clinical TrialNASDAQ:KRBPKiromic BioPharma Inc
22/05/202423h03Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
21/05/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
20/05/202423h00Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:KRBPKiromic BioPharma Inc
20/05/202414h00Business WireKiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial SiteNASDAQ:KRBPKiromic BioPharma Inc
20/05/202412h29Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:KRBPKiromic BioPharma Inc
17/05/202422h43Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:KRBPKiromic BioPharma Inc
24/04/202414h08Business WireKiromic BioPharma Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three PatientsNASDAQ:KRBPKiromic BioPharma Inc
19/04/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
10/04/202422h30Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:KRBPKiromic BioPharma Inc
05/04/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
02/04/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:KRBP

Kürzlich von Ihnen besucht

USOTC
DTEGY
Deutsche Telekom (QX)
TG
DTE
Deutsche Telekom
USOTC
ADDYY
Adidas (QX)
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
TSLA
Tesla
TG
MBG
MercedesBenz
NYSE
DIS
Walt Disney
TG
RHM
Rheinmetall
COIN
ADAUSD
Cardano
CCOM
US500
US 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
TG
TUI1
Tui
TG
432
Arbor Metals
COIN
DOGEUSD
Dogecoin
COIN
ETHUSD
Ethereum
CCOM
SILVER
SILVER
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten